Literature DB >> 2626050

Lack of diurnal variation in plasma levels of androstenedione, testosterone, estrone and estradiol in postmenopausal women.

P E Lønning1, M Dowsett, S Jacobs, B Schem, J Hardy, T J Powles.   

Abstract

Plasma 4-en-androstenedione, testosterone, estradiol and estrone were measured during the day in six healthy postmenopausal women and in six breast cancer patients, three of whom received treatment with glucocorticoids. Blood samples were obtained at 8 a.m., 10 a.m., 12 noon, 4 p.m., 8 p.m. and 12 midnight. There was a considerable variation in plasma levels of all steroids during the day; for 4-en-androstenedione the mean within patient coefficient variation was 61.4%, for testosterone it was 28.9%, for estrone it was 17.8% and for estradiol it was 29.2%. While the plasma levels for all steroids tended to be higher in the morning than in the evening, the changes were not statistically significant (Friedman's test: P greater than 0.10). We conclude that although a moderate diurnal variation in the plasma level of these steroids may occur, it is of a moderate magnitude compared to variations due to other causes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2626050     DOI: 10.1016/0022-4731(89)90143-x

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  4 in total

1.  Smoking as a determinant for plasma levels of testosterone, androstenedione, and DHEAs in postmenopausal women.

Authors:  Jonas Manjer; Robert Johansson; Per Lenner
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 2.  Mutual Shaping of Circadian Body-Wide Synchronization by the Suprachiasmatic Nucleus and Circulating Steroids.

Authors:  Yifan Yao; Rae Silver
Journal:  Front Behav Neurosci       Date:  2022-06-01       Impact factor: 3.617

3.  Genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women.

Authors:  Jennifer Prescott; Deborah J Thompson; Peter Kraft; Stephen J Chanock; Tina Audley; Judith Brown; Jean Leyland; Elizabeth Folkerd; Deborah Doody; Susan E Hankinson; David J Hunter; Kevin B Jacobs; Mitch Dowsett; David G Cox; Douglas F Easton; Immaculata De Vivo
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

4.  The influence of CGS 16949A on peripheral aromatisation in breast cancer patients.

Authors:  P E Lønning; S Jacobs; A Jones; B Haynes; T Powles; M Dowsett
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.